Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 17/20 | 0.64 |
| ▸ | DRD2 | P14416 | 15/20 | 0.64 |
| ▸ | DRD4 | P21917 | 10/20 | 0.64 |
| ▸ | ADRA1A | P35348 | 5/20 | 0.64 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.58 |
| ▸ | HTR1A | P08908 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | HTR2A | P28223 | 1/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.57 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7526939 | 0.91 | DRD3 (0.77) | DRD3DRD2DRD4ADRA1ASLC6A2 | |
| SCHEMBL7530035 | 0.89 | DRD3 (0.79) | DRD3DRD2DRD4ADRA1ASLC6A2 | |
| SCHEMBL7531760 | 0.88 | DRD3 (0.63) | DRD3DRD2DRD4ADRA1ASLC6A2 | |
| SCHEMBL7531662 | 0.87 | DRD3 (0.67) | DRD3DRD2DRD4ADRA1ASLC6A2 | |
| Hydrochloric Acid SCHEMBL7526148 | 0.87 | DRD3 (0.62) | DRD3DRD2DRD4ADRA1ASLC6A2 | |
| Hydrochloric Acid SCHEMBL7350351 | 0.81 | DRD2 (0.76) | DRD3DRD2DRD4ADRA1ASLC6A2 | |
| SCHEMBL7529338 | 0.81 | DRD2 (0.79) | DRD3DRD2DRD4ADRA1ASLC6A4 | |
| Hydrochloric Acid SCHEMBL7526532 | 0.80 | DRD2 (0.78) | DRD3DRD2DRD4ADRA1ASLC6A2 | |
| SCHEMBL7528464 | 0.79 | DRD2 (0.79) | DRD3DRD2DRD4ADRA1ASLC6A2 | |
| SCHEMBL7436346 | 0.78 | DRD2 (1.00) | DRD3DRD2DRD4ADRA1ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0898567-B1 | N-AMINOALKYL-1-BIPHENYLENYL-2-CARBOXAMIDES; DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORP (US) | 2002-04-03 | — | — | EP | claimed |
| EP-0898567-B1 | N-AMINOALKYL-1-BIPHENYLENYL-2-CARBOXAMIDES; DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORP (US) | 2002-04-03 | — | — | EP | disclosed |
| EP-0898567-A1 | NOVEL N-AMINOALKYL-1-BIPHENYLENYL-2-CARBOXAMIDES; NEW DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1999-03-03 | — | — | EP | disclosed |
| WO-1997038990-A1 | NOVEL N-AMINOALKYL-1-BIPHENYLENYL-2-CARBOXAMIDES; NEW DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS | NEUROGEN CORPORATION (US) | 1997-10-23 | — | — | WO | disclosed |